Evidence map›Paper›PMID 41444756›Full record

ArticleScientific reports2025

SentXFormer: a transformer-enhanced hybrid deep learning framework for cross-domain sentiment analysis of customer reviews.

Ajeet Kumar, Kumar Abhishek, Ahamed Shafeeq B M

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ajeet KumarDepartment of Computer Science and Engineering, NIT Patna, Patna, Bihar, 800005, India.
Kumar AbhishekDepartment of Computer Science and Engineering, NIT Patna, Patna, Bihar, 800005, India.
Ahamed Shafeeq B MManipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India. ahamed.shafeeq@manipal.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cross domain sentiment analysis is still a difficult task because of vocabulary changes, context change and domain specific sentiment. Conventional models are not known to generalize over unknown areas leading to decreased accuracy and unreliable transfer performance. This paper presents a deep learning model named SentXFormer, which is a transformer-based hybrid framework that enhances the sentiment classification in heterogeneous domains. SentXFormer is based on the hybrid SentiConGRU-Net architecture, which consists of CNN and GRU layers, and contextual embeddings of BERT, RoBERTa, and Domain-Adaptive BERT (DABERT). A domain adaptation module based on an adversarial training with a Gradient Reversal Layer (GRL) also encourages domain-invariant representations to be learned. The experiments are done on 23,440 sentiment-labeled reviews across three publicly available datasets including Amazon (7,550 samples), Yelp (8,450 samples), and IMDB (7,440 samples). SentXFormer performed well in in-domain, reaching 98.7% (Amazon), 97.67% (Yelp) and 98.8% (IMDB) accuracies. The model is stable in terms of transferability in cross-domain settings with an accuracy of 91-93% on all train-test combinations. The comparative analysis with LSTM, CNN, GRU, and latest transformer-based adaptation models demonstrates that SentXFormer is always better than the current baselines. The findings indicate that SentXFormer is an efficient, strong and scalable tool to sentiment analysis in heterogeneous and real-life customer review contexts.

Indexed as

BERTCNN-GRUCross-DomainCustomer reviewsDABERTDomain adaptationGRLHybrid deep learningSentiment analysisTransformer

Identifiers

PMID41444756
PMCPMC12847699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.